PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematologic Oncology, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong Province, China.\', \'Department of ICU, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong Province, China.\', \'State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, Guangdong Province, China.\', \'Department of Tuberculosis, Fuzhou Pulmonary Hospital, Teaching Hospital of Fujian Medical University, Fuzhou, 350008, Fujian Province, China.\', \'Department of Immunology and Inflammation, Haematology Research Centre, Imperial College London, London, UK. robertpetergale@alumni.ucla.edu.\', \'Department of Hematologic Oncology, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong Province, China. liangyang@sysucc.org.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41375-020-0848-3
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 32372026
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all